Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032850 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Prathibha R Gajjala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH 45267-0564, USA. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Wilms Tumor, Kidney Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that is often fatal due to the formation of irreversible scar tissue in the distal areas of the lung. Although the pathological and radiological features of IPF lungs are well defined, the lack of insight into the fibrogenic role of fibroblasts that accumulate in distinct anatomical regions of the lungs is a critical knowledge gap. Fibrotic lesions have been shown to originate in the subpleural areas and extend into the lung parenchyma through processes of dysregulated fibroproliferation, migration, fibroblast-to-myofibroblast transformation, and extracellular matrix production. Identifying the molecular targets underlying subpleural thickening at the early and late stages of fibrosis could facilitate the development of new therapies to attenuate fibroblast activation and improve the survival of patients with IPF. Here, we discuss the key cellular and molecular events that contribute to (myo)fibroblast activation and subpleural thickening in IPF. In particular, we highlight the transcriptional programs involved in mesothelial to mesenchymal transformation and fibroblast dysfunction that can be targeted to alter the course of the progressive expansion of fibrotic lesions in the distal areas of IPF lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH 45267-0564, USA.
ORCID-Profile: Priyanka Singh, Varshini Odayar, Harshavardhana H Ediga, Satish K Madala
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
Zitieren
APA
Gajjala, P. R., Singh, P., Odayar, V., Ediga, H. H., McCormack, F. X., & Madala, S. K. (2023). Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032850
Vancouver
Gajjala PR, Singh P, Odayar V, Ediga HH, McCormack FX, Madala SK. Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032850
BibTeX
@article{Gajjala2023,
author = {Gajjala, Prathibha R and Singh, Priyanka and Odayar, Varshini and Ediga, Harshavardhana H and McCormack, Francis X and Madala, Satish K},
title = {Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032850}
}
EUVIMED